publication date: Jun. 15, 2018

In Brief

NCI’s Rosenberg receives Jacobson Innovation Award of the American College of Surgeons

Steven Rosenberg received the 2018 Jacobson Innovation Award of the American College of Surgeons.

Rosenberg is chief of the NCI Surgery Branch and a professor of surgery at the Uniformed Services University of Health Sciences, and at the George Washington University School of Medicine and Health Sciences.

The Jacobson Innovation Award honors living surgeons who have been innovators of a new development or technique in any field of surgery and is made possible through a gift from Julius Jacobson. Jacobson is a general vascular surgeon known for his pioneering work in the development of microsurgery.

Rosenberg was awarded with this international surgical prize for his pioneering role in the development of immunotherapy and gene therapy.  When Rosenberg began his work in immunotherapy in the late 1970s, very little was known about T lymphocyte function in cancer and there was no convincing evidence that any immune reaction existed in patients against their cancers.  

Rosenberg developed the first effective immunotherapies for selected patients with advanced cancer, and was the first to successfully insert foreign genes into humans. His studies of cell transfer immunotherapy resulted in durable complete remissions in patients with metastatic melanoma. Additionally, his studies of the adoptive transfer of genetically modified lymphocytes resulted in the regression of metastatic cancer in patients with melanoma, sarcomas, and lymphomas.

In his current role at NCI, Rosenberg oversees the Surgery Branch’s extensive clinical program aimed at translating scientific advances into effective immunotherapies for cancer patients.  

Rosenberg’s current research is focused on defining the host immune response of patients to their cancers.  These studies emphasize the … Continue reading NCI’s Rosenberg receives Jacobson Innovation Award of the American College of Surgeons

To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2020 The Cancer Letter Inc.